Lorazepam EP Impurity C | CAS 2955-37-5 - Request Quote
Lorazepam EP Impurity C
| SZ CAT No: | SZ-L093004 |
| CAS No | 2955-37-5 |
| Mol.F. | C15H10Cl2N2O2 |
| Mol.Wt. | 321.2 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lorazepam EP Impurity C is chemically 7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide. Lorazepam EP Impurity C is supplied with detailed characterization data compliant with regulatory guideline. Lorazepam EP Impurity C can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lorazepam.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2955-37-5
Purchase 2955-37-5
Order 2955-37-5
Enquire 2955-37-5
price of 2955-37-5
2955-37-5 Supplier
2955-37-5 Manufacturer
2955-37-5 Exporter
buy high quality Lorazepam EP Impurity C
Purchase Lorazepam EP Impurity C
Lorazepam EP Impurity C suppliers
Lorazepam EP Impurity C manufacturers
Lorazepam EP Impurity C price
Order Lorazepam EP Impurity C
Enquire Lorazepam EP Impurity C
Lorazepam EP Impurity C cost
Lorazepam EP Impurity C Supplier
Lorazepam EP Impurity C Distributor
Lorazepam EP Impurity C for Method Validation
Lorazepam Reference Standard
Lorazepam EP Impurity C for ANDA Filing
Lorazepam EP Impurity C for Forced Degradation Studies
Lorazepam EP Impurity C Identification Standards
Lorazepam EP Impurity C for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


